Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01588951 · OUTCOME

Relapse Free Survival

Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior · Source last updated 2018-08-14

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of participants
Interval / dispersion
Not reported
Time frame
2 years

What was measured

Percentage of participants alive and without relapsed disease at two years.

Groups in this outcome

No Leukemia Stem Cells - Consolidation

Without LSC, standard cytarabine consolidation Cytarabine consolidation: Cytarabine-based consolidation per institutional standards.

Leukemia Stem Cells - Consolidation

LSC present, randomized to cytarabine consolidation Cytarabine consolidation: Cytarabine-based consolidation per institutional standards.

Leukemia Stem Cells - Transplant

LSC present, randomized to allogeneic transplant Allogeneic transplant: Allogeneic stem cell transplant per institutional standards.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
No Leukemia Stem Cells - Consolidation2
Leukemia Stem Cells - Consolidation2
Leukemia Stem Cells - Transplant5

Reported measurements

Source class 1
Values in percentage of participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
No Leukemia Stem Cells - Consolidation0Not reportedNot reportedNot reportedNot reported
Leukemia Stem Cells - Consolidation0Not reportedNot reportedNot reportedNot reported
Leukemia Stem Cells - Transplant0Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        0
      2. group Id
        OG001
        value
        0
      3. group Id
        OG002
        value
        0
denoms
  1. counts
    1. group Id
      OG000
      value
      2
    2. group Id
      OG001
      value
      2
    3. group Id
      OG002
      value
      5
    units
    Participants
description
Percentage of participants alive and without relapsed disease at two years.
groups
  1. description
    Without LSC, standard cytarabine consolidation Cytarabine consolidation: Cytarabine-based consolidation per institutional standards.
    id
    OG000
    title
    No Leukemia Stem Cells - Consolidation
  2. description
    LSC present, randomized to cytarabine consolidation Cytarabine consolidation: Cytarabine-based consolidation per institutional standards.
    id
    OG001
    title
    Leukemia Stem Cells - Consolidation
  3. description
    LSC present, randomized to allogeneic transplant Allogeneic transplant: Allogeneic stem cell transplant per institutional standards.
    id
    OG002
    title
    Leukemia Stem Cells - Transplant
param Type
NUMBER
reporting Status
POSTED
time Frame
2 years
title
Relapse Free Survival
type
PRIMARY
unit Of Measure
percentage of participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice